Biomea Fusion, Inc.
BMEA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.02 | 0.54 | 0.11 |
| FCF Yield | -9.55% | -26.27% | -32.90% | -21.38% |
| EV / EBITDA | -3.90 | -1.18 | -1.71 | -3.08 |
| Quality | ||||
| ROIC | 0.00% | -37.76% | -81.04% | -49.84% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | 0.74 | 0.93 | 0.88 | 1.02 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 39.88% | 25.15% | 14.69% | -18.43% |
| Safety | ||||
| Net Debt / EBITDA | 1.91 | 2.43 | 0.96 | 1.67 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -1,508.04 | 0.00 | 0.00 |